Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)

C. S. Liu,C. Elser,Sophie Huang,Gregory R. Pond,Brian O'Sullivan,Eric X. Chen,John Waldron,David Goldstein,Lillian L. Siu,J. Kim

Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)

2008

C. S. Liu
C. Elser
Sophie Huang
Gregory R. Pond
Brian O'Sullivan
Eric X. Chen
John Waldron
David Goldstein
Lillian L. Siu
J. Kim

6052 Background: CRT with high dose CDDP 100mg/m2×3 and radiation (RT) 70Gy/35f/7weeks is a standard treatment option in patients (pts) with LA-HNSCC. Whether the delivery of less than the intended...

Keywords:

Pathology
Cisplatin
Cancer research
Oncology
Head and neck squamous-cell carcinoma
Internal medicine
Medicine
locally advanced
concurrent chemoradiation
dose intensity
Standard treatment
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations